National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine
An antigen-specific DNA cancer vaccine consisting of the coding sequences of a signal peptide (pNGVL4a-Sig), a detox form of the human papillomavirus type 16 (HPV-16) antigen E7, and the heat shock protein 70 (HSP70). Upon administration, this vaccine may generate potent cytotoxic CD8(+) T-cell responses against E7-expressing tumor cells, resulting in tumor cell death. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:plicamycin, plitidepsin, pneumococcal polyvalent vaccine, Pneumovax 23, pNGVL3-hICD vaccine
Next:PNP-expressing ovine atadenovirus FP253, Pnu-Imune 23, polifeprosan 20 with carmustine implant, Polo-like kinase 1 inhibitor GSK-461364, Polo-like kinase 1 inhibitor ON 01910.Na

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov